Please click here to log in with you RCPsych web account details; you will be redirected back to CPD Online.If you have forgotten your College web account details, you will be able to reset them here.
Please click here to log in if your institution has a subscription to CPD Online with Athens access.
Please click here to log in if you are subscribed through Medicom Netherlands.
If you having troubles signing in with the options above, please try this alternative login route.
by Professor Fabrizio
Schifano and Dr Antonio
Last updated: February 2019
In the second half of the 1990s, a global
trend of escalating stimulant misuse (such as cocaine, amphetamine,
methamphetamine, methylenedioxymethamphetamine/ MDMA and MDMA-like
drugs, cathinone derivatives, and benzylpiperazine/BZP) was
observed across a number of EU countries.
When reorganising statutory and non-statutory services to
cope with this increasingly widespread clinical issue, the
epidemiological approach is of paramount importance, and a clear
appreciation of the levels of stimulant misuse is necessary in
order to allocate the appropriate levels of resources.
Stimulant misuse is typically associated with an imbalance of
neurotransmitters, especially dopamine. Therefore, practising
psychiatrists need to be aware of the psychopathological
consequences related to substance misuse in order to refine
their own diagnostic and clinical management skills.
treatment approaches and organising services by Prof Fabrizio
Schifano and Dr Antonio Albanese
brain damage by Prof Kenneth Wilson, Dr Joy Bell and Dr Vanessa
Buprenorphine in opioid dependence by Dr
Lucinda M. Cockayne and Ms Elizabeth Hutchings
Helping the addicted doctor by Dr Elizabeth Hare
and Dr Malcolm Bruce
Drug Misuse: Psychosocial Interventions - The NICE Guideline
(book from RCPsych publications)
Related Advances articles
Download take-home notes to print and